Zhongmin Wang
Fortune : 361 M $ au 31/08/2026
Fortune : 361 M $ au 31/08/2026
Zhongmin Wang is the founder of Akeso, Inc., founded in 2012, and holds the titles of Executive Director and Senior Vice President.
Former job includes Senior Director at Crown Bioscience, Inc. Education history includes undergraduate degree from the University of Science & Technology of China (1991), doctorate from Baylor College of Medicine (1998), and graduate degree from Northeastern University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKESO, INC. 3,42% | 04/09/2026 | 31 492 881 ( 3,42% ) | 361 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AKESO, INC. | Fondateur | 01/03/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Commercial Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akeso, Inc.
Akeso, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutic antibodies to patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national